← All trials
NCT00806403
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2001
- Primary completion
- Jun 1, 2003
- Completion date
- Jun 1, 2004
- First posted
- —
- Last posted
- —
- Enrollment
- 205
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of GothenburgLead sponsor
- Stockholm South General HospitalStudy chair
- University of GothenburgStudy chair
- University of GothenburgOverall official - principal investigator
- Orebro UniversityCollaborator
- Stockholm South General HospitalCollaborator
- Norra Alvsborgs Lans Hospital, TrollhattanCollaborator
- Varberg Hospital, SwedenCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.